UNSPSC 51283220: Oleandomycin phosphate

This classification denotes a macrolide antibiotic with the molecular formula C35H61NO12.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8681H0C27P, chemically known as oleandomycin, phosphate (1:1) (salt) but more generally known as oleandomycin phosphate, which bears US NIH Compound Identifier 72492. European Medicines Agency schedules Oleandomycin phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03497MIG.

UNSPSC 51283220 Oleandomycin phosphate is a Commodity code that covers antibiotic pharmaceutical products, though recent state and local procurement activity under this specific code designation shows limited alignment with the nominal scope. The two opportunities tagged to this code in the recent record involve different pharmaceutical products entirely: a completed piggyback award from the Illinois Department of Public Health for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, and a competitive solicitation from Seminole County, Florida for Naloxone and drug deactivation systems. State and local health and safety agencies are the primary issuing bodies engaging in pharmaceutical procurement under this code frame, with departments of public health and county health authorities leading activity.

Recent opportunities span Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (bid number 26-482DPH-PREPD-B-53392) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under a 12-month initial term with two one-year renewal options. Seminole County, Florida issued an IFB (number IFB60459723LAS) on June 30, 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the original response deadline was July 26, 2023 (note: the posted date and response date show an inconsistency in the source record). The code shows active but narrow recent state and local procurement volume, concentrated in health-department and county-level procurements for emergency-response and disease-management pharmaceuticals rather than oleandomycin phosphate specifically.